Education
About Us
Working with TipRanks
Follow Us
Definitive Healthcare Corp (DH)
NASDAQ:DH
DH Stock Chart & Stats
$2.95
-$0.06(-1.41%)
At close: 4:00 PM EST
$2.95
-$0.06(-1.41%)
Day’s Range― - ―
52-Week Range$2.15 - $5.68
Previous CloseN/A
Volume69.97K
Average Volume (3M)338.90K
Market Cap
$408.92M
Enterprise Value$517.95M
Total Cash (Recent Filing)$184.20M
Total Debt (Recent Filing)$8.92M
Price to Earnings (P/E)―
Beta1.73
Next Earnings
Nov 06, 2025EPS Estimate
0.06Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.07
Shares Outstanding104,086,210
10 Day Avg. Volume311,870
30 Day Avg. Volume338,897
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap1.27
Enterprise Value/Revenue2.11
Enterprise Value/Gross Profit2.77
Enterprise Value/Ebitda-1.30
Forecast
1Y Price Target
$4.66Price Target Upside57.97% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering8
Bulls Say, Bears Say
Bulls Say
Earnings And Cash FlowDH is winning some new accounts, and the earnings power and cash flow are strong.
Renewal RatesManagement reported the highest retention rate since the second quarter of last year, indicating early signs of improvement in renewal rates.
Revenue GuidanceThere is a raise to the low end of the FY25 revenue guidance range, which is encouraging.
Bears Say
Churn ConcernsChurn remains a topic to monitor, with impacts in the quarter being almost exclusive to SMB customers.
Macro-environment ChallengesThe biggest challenges facing DH are the overall macro-environment, some elongated decision-making processes, y/y declines in revenue, and continuing attrition.
Revenue DeclineRevenue still declined -5% y/y, and the number of Enterprise customers declined -5% y/y to 510.
Definitive Healthcare Corp News
DH FAQ
What was Definitive Healthcare Corp’s price range in the past 12 months?
Definitive Healthcare Corp lowest stock price was $2.15 and its highest was $5.68 in the past 12 months.
What is Definitive Healthcare Corp’s market cap?
Definitive Healthcare Corp’s market cap is $408.92M.
When is Definitive Healthcare Corp’s upcoming earnings report date?
Definitive Healthcare Corp’s upcoming earnings report date is Nov 06, 2025 which is in 13 days.
How were Definitive Healthcare Corp’s earnings last quarter?
Definitive Healthcare Corp released its earnings results on Aug 07, 2025. The company reported $0.07 earnings per share for the quarter, beating the consensus estimate of $0.05 by $0.02.
Is Definitive Healthcare Corp overvalued?
According to Wall Street analysts Definitive Healthcare Corp’s price is currently Undervalued.
Does Definitive Healthcare Corp pay dividends?
Definitive Healthcare Corp does not currently pay dividends.
What is Definitive Healthcare Corp’s EPS estimate?
Definitive Healthcare Corp’s EPS estimate is 0.06.
How many shares outstanding does Definitive Healthcare Corp have?
Definitive Healthcare Corp has 104,086,210 shares outstanding.
What happened to Definitive Healthcare Corp’s price movement after its last earnings report?
Definitive Healthcare Corp reported an EPS of $0.07 in its last earnings report, beating expectations of $0.05. Following the earnings report the stock price went down -2.771%.
Which hedge fund is a major shareholder of Definitive Healthcare Corp?
Currently, no hedge funds are holding shares in DH
Definitive Healthcare Corp Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$4.66 (57.97% Upside)
$4.66 (57.97% Upside)
Hedge Fund Trend
Decreased
By 102.6K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Negative
20 days / 200 days
Momentum
-35.79%
12-Months-Change
Fundamentals
Return on Equity
-64.27%
Trailing 12-Months
Asset Growth
-45.86%
Trailing 12-Months
Company Description
Definitive Healthcare Corp
Definitive Healthcare Corp (DH) is a leading provider of data and analytics solutions for the healthcare industry. The company specializes in delivering comprehensive information on healthcare providers, payers, and patients, enabling clients to make informed decisions. Its core products include a robust platform that aggregates vast datasets, offering insights into market dynamics, provider performance, and healthcare trends. DH serves a diverse clientele, including life sciences companies, healthcare providers, and payers, helping them to optimize their strategies and operations.
DH Company Deck
DH Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed view with positive developments in customer retention and new business, alongside challenges from revenue decline and macroeconomic pressures. The company's actions to improve customer success and leverage data partnerships are promising, but ongoing challenges in certain segments and the broader economic environment remain concerns.View all DH earnings summariesDH Stock 12 Month Forecast
Average Price Target
$4.66
▲(57.97% Upside)
Technical Analysis
Ownership Overview
8.70% Insiders
5.12% Mutual Funds
0.18% Other Institutional Investors
80.71% Public Companies and
Individual Investors